65-16,129 Pharmacists authorized to administer drugs, when; exceptions.
65-16,129. Pharmacists authorized to administer drugs, when; exceptions. (a) (1) A licensed pharmacist may administer a drug by injection that, in the judgment of the prescriber, may be safely self-administered by a patient, to a patient pursuant to a prescription order, unless the prescription order includes the words “not to be administered by a pharmacist,” […]
65-16,130 Telepharmacy; definitions; requirements for operation; state board of pharmacy rules and regulations.
65-16,130. Telepharmacy; definitions; requirements for operation; state board of pharmacy rules and regulations. (a) As used in this section: (1) “Telepharmacy” means the practice of pharmacy by a pharmacist located in Kansas using telecommunications or other automations and technologies to deliver personalized, electronically documented, real-time pharmaceutical care to patients or their agents, who are located […]
65-16,121 Pharmacy audit integrity act.
65-16,121. Pharmacy audit integrity act. (a) K.S.A. 65-16,121 through 65-16,126, and amendments thereto, shall be known and may be cited as the pharmacy audit integrity act. (b) This section shall take effect on and after July 1, 2011. History: L. 2011, ch. 114, § 1; June 9.
65-16,122 Same; definitions.
65-16,122. Same; definitions. (a) As used in this act, “pharmacy benefits manager” or “PBM” means a person, business or other entity that performs pharmacy benefits management. The term includes a person or entity acting for a PBM in contractual or employment relationship in the performance of pharmacy benefits management for a managed care company, not-for-profit […]
65-16,123 Same; procedural requirements.
65-16,123. Same; procedural requirements. (a) The entity conducting the audit shall follow the following procedures: (1) An entity conducting an on-site audit must give the pharmacy at least seven days written notice before conducting an initial audit; (2) an audit that involves clinical or professional judgment must be conducted by or in consultation with a […]
65-16,124 Same; audit reports; recoupment and repayment of funds; access to audit information.
65-16,124. Same; audit reports; recoupment and repayment of funds; access to audit information. (a) Any preliminary audit report must be delivered to the pharmacy within 60 days after the conclusion of the audit. Any pharmacy shall be allowed at least 30 days following receipt of the preliminary audit to provide documentation to address any discrepancy […]
65-16,125 Same; final report; availability.
65-16,125. Same; final report; availability. (a) Any auditing entity, upon request of the plan sponsor, shall provide a copy of the final report, including the disclosure of any money recouped in the audit. The pharmacy may provide a copy of the report to the commissioner of insurance, provided such report shall not contain any personally […]
65-16,126 Same; application of the act.
65-16,126. Same; application of the act. (a) This act shall apply to contracts between an auditing entity and a pharmacy entered into, extended or renewed on or after the effective date of this act. This act shall not apply to any audit, review or investigation that is initiated based upon suspected or alleged fraud, willful […]
65-16,127 Emergency opioid antagonists; dispensing, storing and administering; duties of the state board of pharmacy and first responder agencies; rules and regulations.
65-16,127. Emergency opioid antagonists; dispensing, storing and administering; duties of the state board of pharmacy and first responder agencies; rules and regulations. (a) As used in this section: (1) “Bystander” means a family member, friend, caregiver or other person in a position to assist a person who the family member, friend, caregiver or other person […]
65-16,128 Electronic transmission of prescription orders required, when; exceptions.
65-16,128. Electronic transmission of prescription orders required, when; exceptions. (a) Every prescription order issued for a controlled substance in schedules II-V that contains an opiate, as described in the uniform controlled substances act, shall be transmitted electronically unless: (1) Electronic prescription orders are not possible due to technological or electronic system failures; (2) electronic prescribing […]